Middle East & Africa Enzyme Replacement Therapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Enzyme Type (Alglucosidase Alfa, Agalsidase Beta, Imiglucerase, Idursulfase, Galsulfase, Velaglucerase Alfa, and Other Enzymes), Therapeutic Conditions (Gaucher's Disease, Fabry's Disease, MPS, Pompe's Disease, SCID, and Other Therapeutic Conditions), Route of Administration (Parenteral and Oral), and End User (Hospitals, Infusion Centers, and Others)

No. of Pages: 162    |    Report Code: BMIRE00027293    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Enzyme Replacement Therapy Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Enzyme Replacement Therapy Market – By Enzyme Type

1.3.2        MEA Enzyme Replacement Therapy Market – By Therapeutic Conditions

1.3.3        MEA Enzyme Replacement Therapy Market – By Route of Administration

1.3.4        MEA Enzyme Replacement Therapy Market – By End User

1.3.5        MEA Enzyme Replacement Therapy Market – By Country

2.           MEA Enzyme Replacement Therapy Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Enzyme Replacement Therapy Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East & Africa – PEST Analysis

4.3         Expert Opinion

5.           MEA Enzyme Replacement Therapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Lysosomal Storage Diseases (LSDs)

5.1.2        Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation

5.2         Market Restraints

5.2.1        Cutthroat Competition among Market Players

5.3         Market Opportunities

5.3.1        Increasing Partnerships and Collaborations to Synergize the Business

5.4         Future Trends

5.4.1        Innovative Developments in ERT

5.5         Impact Analysis

6.           Enzyme Replacement Therapy Market– MEA Analysis

6.1         MEA Enzyme Replacement Therapy Market Revenue Forecast and Analysis

7.           MEA Enzyme Replacement Therapy Market Revenue and Forecasts To 2028– by Enzyme Type

7.1         Overview

7.2         MEA Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)

7.3         Alglucosidase Alfa

7.3.1        Overview

7.3.2        Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)

7.4         Agalsidase Beta

7.4.1        Overview

7.4.2        Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)

7.5         Imiglucerase

7.5.1        Overview

7.5.2        Imigluceras - Revenue and Forecast to 2028 (US$ Million)

7.6         Idursulfase

7.6.1        Overview

7.6.2        Idursulfase - Revenue and Forecast to 2028 (US$ Million)

7.7         Galsulfase

7.7.1        Overview

7.7.2        Galsulfase - Revenue and Forecast to 2028 (US$ Million)

7.8         Velaglucerase Alfa

7.8.1        Overview

7.8.2        Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)

7.9         Other Enzymes

7.9.1        Overview

7.9.2        Other Enzymes - Revenue and Forecast to 2028 (US$ Million)

8.           MEA Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Therapeutic Conditions

8.1         Overview

8.2         MEA Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)

8.3         Gaucher's Disease

8.3.1        Overview

8.3.2        Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Fabry's Disease

8.4.1        Overview

8.4.2        Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Mucopolysaccharidosis (MPS)

8.5.1        Overview

8.5.2        MPS - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Pompe's Disease

8.6.1        Overview

8.6.2        Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.7         SCID

8.7.1        Overview

8.7.2        SCID - Market Revenue and Forecast to 2028 (US$ Million)

8.8         Other Therapeutic Conditions

8.8.1        Overview

8.8.2        Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Route of Administration

9.1         Overview

9.2         MEA Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)

9.3         Parenteral

9.3.1        Overview

9.3.2        Parenteral - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Oral

9.4.1        Overview

9.4.2        Oral - Market Revenue and Forecast to 2028 (US$ Million)

10.        MEA Enzyme Replacement Therapy Market Analysis– By End User

10.1      Overview

10.2      MEA Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

10.4      Infusion Centers

10.4.1     Overview

10.4.2     Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others - Market Revenue and Forecasts To 2028 (US$ Million)

11.        MEA Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Middle East & Africa Enzyme Replacement Therapy Market

11.1.1     Overview

11.1.2     Middle East & Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Country (%)

11.1.2.1       Saudi Arabia: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       Overview

11.1.2.1.2       Saudi Arabia Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.3       Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

11.1.2.1.4       Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)

11.1.2.1.5       Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)

11.1.2.1.6       Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)

11.1.2.2       South Africa: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Overview

11.1.2.2.2       South Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.3       South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

11.1.2.2.4       South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)

11.1.2.2.5       South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)

11.1.2.2.6       South Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)

11.1.2.3       UAE: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       Overview

11.1.2.3.2       UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.3       UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

11.1.2.3.4       UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)

11.1.2.3.5       UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)

11.1.2.3.6       UAE: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)

11.1.2.4       Rest of the Middle East and Africa: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.1       Overview

11.1.2.4.2       Rest of the Middle East and Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

11.1.2.4.3       Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

11.1.2.4.4       Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Therapeutic Conditions (US$ Million)

11.1.2.4.5       Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By Route of Administration (US$ Million)

11.1.2.4.6       Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast To 2028, By End User (US$ Million)

12.        MEA Enzyme Replacement Therapy Market–Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Sanofi

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      BioMarin Pharmaceutical Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AbbVie Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Alexion Pharmaceuticals, Inc. (AstraZeneca)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     WOT Analysis

13.6.6     Key Developments

13.7      Amicus Therapeutics

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Recordati S.p.A.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CHIESI Farmaceutici S.p.A.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Pfizer Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

Table 2.             Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)

Table 3.             Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 4.             Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 5.             South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

Table 6.             South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)

Table 7.             South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 8.             South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 9.             UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

Table 10.          UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)

Table 11.          UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 12.          UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 13.          Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Enzyme Type (US$ Million)

Table 14.          Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Therapeutic Conditions (US$ Million)

Table 15.          Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 16.          Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 17.          Recent Inorganic Growth Strategies in the MEA enzyme replacement therapy market

Table 18.          Recent Organic Growth Strategies in the MEA enzyme replacement therapy market

Table 19.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           MEA Enzyme Replacement Therapy Market Segmentation

Figure 2.           MEA Enzyme Replacement Therapy Market Segmentation, By Country

Figure 3.           MEA Enzyme Replacement Therapy Market Overview

Figure 4.           MEA Enzyme Replacement Therapy Market, By Enzyme Type

Figure 5.           MEA Enzyme Replacement Therapy Market, By Country

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           MEA Impact Analysis

Figure 9.           MEA Enzyme Replacement Therapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        MEA Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)

Figure 11.        MEA Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        MEA Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        MEA Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        MEA Idursulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        MEA Galsulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        MEA Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        MEA Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        MEA Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)

Figure 19.        MEA Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        MEA Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        MEA MPS - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        MEA Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        MEA SCID - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        MEA Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        MEA Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)

Figure 26.        MEA Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        MEA Oral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        MEA Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)

Figure 29.        MEA Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        MEA Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        MEA Others- Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.        Middle East & Africa Enzyme Replacement Therapy Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 33.        Middle East & Africa Enzyme Replacement Therapy Market Revenue and Forecast to 2028, by Country (%)

Figure 34.        Saudi Arabia: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

Figure 35.        South Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

Figure 36.        UAE: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Rest of the Middle East and Africa: Enzyme Replacement Therapy Market Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Middle East & Africa Enzyme Replacement Therapy Market

  1. Sanofi.
  2. BioMarine Pharmaceutical Inc.
  3. Takeda Pharmaceutical Company Limited.
  4. AbbVie Inc.
  5. Janssen Pharmaceutical ( Johnson & Johnson Services,Inc.).
  6. Alexion Pharmaceutical, Inc.(AstaZeneca).
  7. Amicus Therapeutics.
  8. Recordati S.p.A.
  9. CHIESI farmaceutici S.p.A.
  10. Pfizer Inc.